Here are the 10 biggest losers among healthcare stocks:
• Neurocrine Biosciences — down 8.9 percent
• Lannett Co — down 8.2 percent
• Horizon Pharma — down 6.9 percent
• Achillion Pharmaceuticals — down 6.5 percent
• Repligen — down 6.3 percent
• Acadia Pharmaceuticals — down 6 percent
• Arena Pharmaceuticals — down 6 percent
• Impax Laboratories — down 5.8 percent
• Incyte — down 5.6 percent
• Cardiovascular Systems — down 5.3 percent on three times the normal volume
More articles on ASC issues:
What is important for ASC leaders to know today? 3 key thoughts from Susan Kizirian
mHealth market to grow at CAGR of nearly 50% by 2020: 4 statistics on the market by service
3 ways to trim down ASC business office costs for more powerful revenue cycle management strategy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.